Tirzepatide with Glycine is an advanced compounded formulation that combines the powerful dual-action GLP-1/GIP medication tirzepatide with glycine , a conditionally essential amino acid that supports cellular repair , detoxification , and anti-inflammatory balance
These agents pleotropic effects have translated into clinicals trials showing improvement in cardiovascular outcomes, improved quality of life and/or heart failure events in heart failure with preserved ejection fraction, resolution of steatohepatitis and improvement in liver fibrosis, prevention and treatment of type 2 diabetes, and improvement in renal function in chronic kidney disease
May interact with other medication: Although it is FDA-approved for its ingredients, individuals with specific medical conditions, notably type 1 diabetes, should tread cautiously
Tirzepatide acts on GIP and GLP-1 receptors simultaneously (twincretin effect) to suppress appetite, enhance insulin release and sensitivity, and delay digestion to control blood sugar levels and reduce calorie intake
Enrolling takes a few minutes As it is for many telehealth providers, enrollment is quick and virtual